'Patients randomized' diaporamas de présentation

Statistics 542 Introduction to Clinical Trials Issues in Analysis of Randomized Clinical Trials

Statistics 542 Introduction to Clinical Trials Issues in Analysis of Randomized Clinical Trials. Issues in Analysis of Randomized Clinical Trials. Reference: May, DeMets et al (1981) Circulation 64:669-673 Peto et al (1976) British Journal of Cancer. Sources of Bias.

980 views • 73 slides

Objective Outcomes

583 views • 40 slides

Updates in hepatocellular cancer and pancreas cancer

Updates in hepatocellular cancer and pancreas cancer. Jordan Berlin, M.D. Ingram Associate Professor, Medicine. Advisory Boards here and there Genentech BMS Imclone Sanofi-Aventis Pfizer Abbott Astra Zeneca Cephalon (not paid) Roche. Spoke for: Genentech Nestle

566 views • 34 slides

The EP Show COMPANION and CARE-HF

The EP Show COMPANION and CARE-HF. Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis, IN Hugh Calkins MD Director, Electrophysiology Lab Johns Hopkins University Medical Center Baltimore, MD John Cleland MD Professor of Cardiology

304 views • 30 slides

Peer Power and Recovery from Addiction

Peer Power and Recovery from Addiction. Presented at the European Federation of Therapeutic Communities Oxford, UK. Keith Humphreys Professor of Psychiatry Veterans Affairs and Stanford University Medical Centers Palo Alto, California.

408 views • 29 slides

Journal Club

236 views • 23 slides

Journal Club

234 views • 23 slides

Dopamine May Decrease Nephrotoxicity in Patients Receiving High-Dose Ifosfamide

Dopamine May Decrease Nephrotoxicity in Patients Receiving High-Dose Ifosfamide. L Johnetta Blakely, SR Patel, PF Thall, X Wang, TA Simmons, JL Beach, TL Armen, LL Chen, MA Burgess, JC Trent, and RS Benjamin UT MD Anderson Cancer Center Houston, United States. Background.

284 views • 16 slides

153 views • 15 slides

Search strategy and results

Search strategy and results. Amir Kashani, et al. Circulation. 2006;114:2788-2797. Baseline Characteristics. CHD indicates coronary heart disease; DM, diabetes mellitus; PMSG, Pravastatin Multinational Study Group; SSSS, Scandinavian Simvastatin Survival Study; HPS,

139 views • 6 slides

Washington University, PIs: Pamela Woodard, M.D. Tammie Benzinger, M.D.

Washington University, PIs: Pamela Woodard, M.D. Tammie Benzinger, M.D.

171 views • 5 slides

DANAMI-2 late

DANAMI-2 late. Objective: To compare fibrinolysis with long distance transport for pPCI . Study: Multicenter, randomized trial (24 referring hospitals , 5 PCI centers).

171 views • 5 slides